Company: VERA
Filing Date: 2025-11-06
Form Type: 8-K
Source: 0001193125-25-268331
Chunk: 1

Company: Vera Therapeutics, Inc.
Filing Date: 2025-11-06
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01      Financial Statements and Exhibits.  

(d) Exhibits.

  Exhibit      Description                                                                    
      No.                                                                                     
     99.1      Slides from Vera Therapeutics’ Corporate Presentation, dated November 6, 2025  
 ──────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document).   

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

                                       Vera Therapeutics, Inc.  
  Date: November 6, 2025      By:      /s/ Marshall Fordyce     
                                       Marshall Fordyce         
                                       Chief Executive Officer